Delaware jury awards Merck biggest-ever patent award of $2.54bn
A Delaware jury has ordered Gilead Sciences to pay $2.54 billion in damages to Merck for infringing a patent related to hepatitis C treatment. It is the largest-ever patent damages award
A jury in the District of Delaware has ordered Gilead Sciences to pay $2.54 billion in damages to Merck for infringing an Idenix Pharmaceuticals patent. This is the largest-ever patent damages award.
The patent covers methods used to develop...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.